Seminars in Pediatric Neurology
Volume 15, Issue 4 , Pages 186-189 , December 2008

Proximal Muscle Weakness in a 15-Year-Old Boy

  • Marcia V. Felker, MD

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Marcia V. Felker, MD, Department of Neurology, Division of Pediatric Neurology, 575 West Drive XE-040, Indianapolis, IN 46202
    • ,
  • Bhuwan P. Garg, MB, BS

References 

  1. Tein I. Metabolic myopathies. In:  Swaiman KF,  Ashwal S,  Ferriero DM editor. Pediatric Neurology. Philadelphia, PA: Principles and Practice; 2006;p. 2023–2073
  2. Strober JB. Congenital myopathies. In:  Swaiman KF,  Ashwal S,  Ferriero DM editor. Pediatric Neurology. Philadelphia, PA: Principles and Practice; 2006;p. 2015–2021
  3. Darras B. Muscular dystrophies. Continuum. 2006;12:33–75
  4. Mitchell CW, Bertorini TE, Shadle M. A boy with proximal weakness and cardiomyopathy. J Clin Neuromuscul Dis. 2006;8:83–91
  5. Rosalki SB. Serum enzymes in disease of skeletal muscle. Clin Lab Med. 1989;9:767–781
  6. Kohler M, Clarenbach CF, Bahler C, et al. Disability and survival in Duchenne muscular dystrophy. J Neurol Neurosurg Psychiatr. 2008;Aug 19, (epub ahead of print)
  7. Gordon E, Pegoraro E, Hoffman H. Limb-girdle muscular dystrophy overview. Gene Review. 2007;June 8, posting
  8. Wicklund MP, Mendell JR. The limb girdle muscular dystrophies (Our ever-expanding knowledge). J Clinical Neuromuscul Dis. 2003;5:12–28
  9. Kugelberg E, Welander L. Heredofamilial juvenile muscular atrophy simulating muscular dystrophy. AMA Arch Neurol Psychiatr. 1956;75:500–509
  10. Pearn J. Incidence, prevalence, and gene frequency studies of chronic childhood spinal muscular atrophy. J Med Genet. 1978;15:409–413
  11. Prior TW. Spinal muscular atrophy diagnostics. J Child Neurol. 2007;22:952–956
  12. Nadeau A, D'Anjou G, Debray G, et al. A newborn with spinal muscular atrophy type 0 presenting with a clincopathological picture suggestive of myotubular myopathy. J Child Neurol. 2007;22:1301–1304
  13. Zerres K, Rudnik-Schoneborn S. Natural history in proximal spinal muscular atrophy—clinical analysis of 445 patients and suggestions for a modification of existing classifications. Arch Neurol. 1995;52:518–523
  14. Chung BH, Wong VC, Ip P. Spinal muscular atrophy: Survival pattern and functional status. Pediatrics. 2004;114:548–553
  15. Russman BS. Spinal muscular atrophy: Clinical classification and disease heterogeneity. J Child Neurol. 2007;22:946–951
  16. Gubitz AK, Feng W, Dreyfuss G. The SMN complex. Exp Cell Res. 2004;296:51–56
  17. Wirth B. An update of the mutation spectrum of the survival motor neuron gene (SMN1) in autosomal recessive spinal muscular atrophy (SMA). Hum Mutat. 2000;15:228–237
  18. Swoboda KJ, Kissel JT, Crawford TO, et al. Perspectives on clinical trials in spinal muscular atrophy. J Child Neurol. 2007;22:957–966
  19. Feldkotter M, Schwarzer V, Wirth R, et al. Quantitative analyses of SMN1 and SMN2 based on real-time lightcycler PCR: Fast and highly reliable carrier testing and prediction of severity of spinal muscular atrophy. Am J Hum Genet. 2002;70:358–368
  20. Gomez MR. Motor neuron diseases in children. In:  Engel AG,  Franzini-Armstrong C editor. New York, NY: Myology; 1994;p. 1837–1857
  21. Rudnik-Schöneborn S, Lützenrath S, Borkowska J, et al. Analysis of creatine kinase activity in 504 patients with proximal spinal muscular atrophy types I-III from the point of view of progression and severity. Eur Neurol. 1998;39:154–162

PII: S1071-9091(08)00080-6

doi: 10.1016/j.spen.2008.10.005

Seminars in Pediatric Neurology
Volume 15, Issue 4 , Pages 186-189 , December 2008

Article Tools